Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-20 4:01 pm Purchase | 2026-02-13 | 13G | Minerva Neurosciences, Inc. NERV | Coastlands Capital LP | 4,563,031 9.990% | 4,563,031 (New Position) | Filing History |
| 2026-02-17 6:12 pm Purchase | 2025-12-23 | 13G | Minerva Neurosciences, Inc. NERV | Logos Global Management LP | 4,435,444 9.900% | 4,435,444 (New Position) | Filing History |
| 2026-02-17 08:12 am Purchase | 2025-12-31 | 13G | Minerva Neurosciences, Inc. NERV | BALYASNY ASSET MANAGEMENT LLC | 4,330,315 9.990% | 4,330,315 (New Position) | Filing History |
| 2026-02-12 09:02 am Purchase | 2025-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Adage Capital Management, L.P. | 2,838,000 6.350% | 2,838,000 (New Position) | Filing History |
| 2026-02-05 2:51 pm Unchanged | 2025-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Farallon Capital Partners L.P. | 4,539,854 9.990% | 0 (Unchanged) | Filing History |
| 2025-12-31 4:30 pm Purchase | 2025-12-23 | 13G | Minerva Neurosciences, Inc. NERV | Vivo Opportunity Fund Holdings, L.P. | 8,591,572 9.990% | 8,591,572 (New Position) | Filing History |
| 2025-12-30 4:05 pm Purchase | 2025-12-23 | 13D | Minerva Neurosciences, Inc. NERV | Boehringer AG | 1,500,225 3.400% | 1,500,225 (New Position) | Filing History |
| 2025-12-29 4:05 pm Purchase | 2025-12-22 | 13G | Minerva Neurosciences, Inc. NERV | Farallon Capital Partners L.P. | 4,539,854 9.990% | 4,539,854 (New Position) | Filing History |
| 2025-12-29 08:29 am Purchase | 2025-12-22 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 9,392,275 19.860% | 8,041,000 (+595.07%) | Filing History |
| 2025-10-28 4:39 pm Purchase | 2025-10-21 | 13D | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,351,275 19.320% | 1,351,275 (New Position) | Filing History |
| 2024-11-12 10:32 am Unchanged | 2024-11-12 | 13G | Minerva Neurosciences, Inc. NERV | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 09:28 am Unchanged | 2024-02-09 | 13G | Minerva Neurosciences, Inc. NERV | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-18 10:21 am Unchanged | 2024-01-18 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-07-07 4:18 pm Unchanged | 2023-07-07 | 13D | Minerva Neurosciences, Inc. NERV | Boehringer AG | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:05 pm Unchanged | 2023-02-14 | 13G | Minerva Neurosciences, Inc. NERV | Point72 Asset Management L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 11:27 am Unchanged | 2023-02-09 | 13G | Minerva Neurosciences, Inc. NERV | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-01 11:16 am Unchanged | 2023-02-01 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-08-23 4:38 pm Unchanged | 2022-08-23 | 13G | Minerva Neurosciences, Inc. NERV | Point72 Asset Management L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 1:53 pm Unchanged | 2022-02-14 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 09:06 am Unchanged | 2022-02-11 | 13G | Minerva Neurosciences, Inc. NERV | Luthringer Remy | 0 0.000% | 0 (Unchanged) | Filing |